Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lagente V et al. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. 1987 Prostaglandins pmid:2438723
Pritchard PH The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration. 1987 Biochem. J. pmid:3689334
Hill CE and Olson MS Stimulation of uric acid release from the perfused rat liver by platelet activating factor or potassium. 1987 Biochem. J. pmid:3689345
Bolin RW et al. Lung endothelial and epithelial permeability after platelet-activating factor. 1987 J. Appl. Physiol. pmid:3693212
Sugiyama T et al. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. 1987 Blood pmid:3580576
Robertson DA et al. Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study. 1987 J. Pharmacol. Exp. Ther. pmid:3694533
Nomura H Biological action and structural specificity of diacylglycerol in platelet activation. 1987 Kobe J Med Sci pmid:3695296
McFall TL et al. Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction. 1987 Pediatr. Res. pmid:3037472
Tysnes OB et al. Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets. 1987 Biochem. Biophys. Res. Commun. pmid:3034251
Barnes PJ et al. The effect of platelet activating factor on pulmonary beta-adrenoceptors. 1987 Br. J. Pharmacol. pmid:3034367
Davenas E et al. Effect of mouse peritoneal macrophages of orally administered very high dilutions of silica. 1987 Eur. J. Pharmacol. pmid:3034632
Kawasaki T and Snyder F The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla. 1987 Biochim. Biophys. Acta pmid:3036238
Shukla SD et al. Activation of phospholipase C in platelets by platelet activating factor and thrombin causes hydrolysis of a common pool of phosphatidylinositol 4,5-bisphosphate. 1987 Biochim. Biophys. Acta pmid:3036249
Grignani G and Jamieson GA Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line. 1987 Invasion Metastasis pmid:3036740
Foegh ML et al. Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959038
Snyder F et al. Measurement of key enzyme activities involved in the metabolism of platelet activating factor. 1987 Meth. Enzymol. pmid:3037250
Robertson DN and Smith GM Role of thromboxane A2, 5-hydroxytryptamine, and platelet activating factor in collagen-induced sudden death in rabbits. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959049
d'Humieres S et al. Platelet activating factor acether is involved in thrombin-induced synthesis of prostacyclin by human endothelial cells. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959051
Ingraham LM et al. In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes. 1987 Br. J. Haematol. pmid:3038160
Whittle BJ et al. Gastric vascular and mucosal damaging actions of platelet activating factor in the canine stomach. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959063
Englberger W et al. Influence of lysophospholipids and PAF on the oxidative burst of PMNL. 1987 Int. J. Immunopharmacol. pmid:3038761
Handley DA et al. Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and immune complex effects in the guinea pig. 1987 Eur. J. Pharmacol. pmid:2959489
Myers AK and Bader TJ Role of adrenal steroids in the recovery from platelet activating factor challenge. 1987 Circ. Shock pmid:3677334
Montrucchio G et al. In vitro oxytocic activity of platelet-activating factor on human myometrium. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960158
Hsueh W et al. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. 1987 FASEB J. pmid:3678700
Mallet AI et al. Platelet activating factor in chronic plaque psoriasis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960170
Terasawa M et al. Antagonistic activity of etizolam on platelet-activating factor in vivo experiments. 1987 Jpn. J. Pharmacol. pmid:3682404
Bourgain RH et al. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960196
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Huber M and Keppler D Inhibition of leukotriene D4 catabolism by D-penicillamine. 1987 Eur. J. Biochem. pmid:3622511
Egido J et al. Role of platelet-activating factor in adriamycin-induced nephropathy in rats. 1987 Eur. J. Pharmacol. pmid:3622604
Kawaguchi H and Yasuda H Effects of platelet-activating factor on conversion of angiotensin I to II. 1987 FEBS Lett. pmid:3622769
Ninio E et al. Biosynthesis of paf-acether. IX. Role for a phosphorylation-dependent activation of acetyltransferase in antigen-stimulated mouse mast cells. 1987 J. Immunol. pmid:3584983
Casals-Stenzel J Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo. 1987 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3587377
Brambilla A et al. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage. 1987 Pharmacol Res Commun pmid:3588650
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Joseph R et al. Sensitivity to PAF is increased in migraine patients. 1987 Thromb. Haemost. pmid:3590077
Bamford CH et al. Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone. 1987 Biochim. Biophys. Acta pmid:3828396
Purdon AD et al. Ionophore-stimulated rat basophilic leukemia cells produce PAF-acether. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3100454
Bruijnzeel PL et al. Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils. 1987 Prostaglandins pmid:3118415
Sha'afi RI and Molski TF Signalling for increased cytoskeletal actin in neutrophils. 1987 Biochem. Biophys. Res. Commun. pmid:3036146
Taylor RR et al. Whole blood platelet aggregation is not affected by cigarette smoking but is sex-related. 1987 Clin. Exp. Pharmacol. Physiol. pmid:3440324
Sperling RI et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. 1987 Arthritis Rheum. pmid:3663263
Siess W and Lapetina EG Phorbol esters sensitize platelets to activation by physiological agonists. 1987 Blood pmid:3663938
Casals-Stenzel J et al. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist. 1987 Br. J. Pharmacol. pmid:3664079
Robertson DN and Page CP Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation. 1987 Br. J. Pharmacol. pmid:3664082
Whittle BJ et al. Increased intestinal formation of Paf in endotoxin-induced damage in the rat. 1987 Br. J. Pharmacol. pmid:3664090
Shigenobu K et al. Potentiation by bovine serum albumin (BSA) of endothelium-dependent vasodilator response to acetyl glyceryl ether phosphorylcholine (AGEPC). 1987 J. Pharmacobio-dyn. pmid:3625454
Jensen NJ et al. FAB MS/MS for phosphatidylinositol, -glycerol, -ethanolamine and other complex phospholipids. 1987 Lipids pmid:3626775
Cox CP and Wood KL Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. 1987 Thromb. Res. pmid:3629553
Ostermann G et al. Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. 1987 Thromb. Res. pmid:3629555
Homma H et al. Some unique features of the metabolic conversion of platelet-activating factor (AGEPC) to alkyl acyl PC by washed rabbit platelets. 1987 Arch. Biochem. Biophys. pmid:3101596
Takahashi H et al. [Blood coagulation disorders in thrombotic thrombocytopenic purpura--with special reference to a von Willebrand factor abnormality]. 1987 Rinsho Byori pmid:3501812
Haroldsen PE et al. Metabolism of platelet-activating factor in isolated perfused rat lung. 1987 J. Clin. Invest. pmid:3108322
Tahara T et al. PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines. 1987 Chem. Pharm. Bull. pmid:3664818
Brigham KL Conference summary: lipid mediators in the pulmonary circulation. 1987 Am. Rev. Respir. Dis. pmid:2820285
Hansen JF and Hansen BF [Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology]. 1987 Ugeskr. Laeg. pmid:3324429
Lamant V et al. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. 1987 Biochem. Pharmacol. pmid:2820421
Haroldsen PE et al. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry. 1987 J. Lipid Res. pmid:3104521
Bienenstock J et al. Mast cell involvement in various inflammatory processes. 1987 Am. Rev. Respir. Dis. pmid:3109295
Levin M et al. Platelet immune complex interaction in the pathogenesis of Kawasaki disease. 1987 Prog. Clin. Biol. Res. pmid:3423040
Violi F et al. Human platelet aggregation by PAF and thromboxane production. 1987 Thromb. Res. pmid:3424290
Muirhead EE Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. 1987 Agents Actions Suppl. pmid:3324720
Mest HJ et al. Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances. 1987 Biomed. Biochim. Acta pmid:3325045
Teng CM et al. Antiplatelet effect of butylidenephthalide. 1987 Biochim. Biophys. Acta pmid:3109495
Kester M et al. Elevation of cytosolic free calcium by platelet-activating factor in cultured rat mesangial cells. 1987 FASEB J. pmid:2442057
Kochanek PM et al. Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia. 1987 Life Sci. pmid:2826947
Valone FH and Johnson B Modulation of platelet-activating-factor-induced calcium influx and intracellular calcium release in platelets by phorbol esters. 1987 Biochem. J. pmid:3322269
Wang J and Dunn MJ Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. 1987 Am. J. Physiol. pmid:2827506
Panetta T et al. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. 1987 Biochem. Biophys. Res. Commun. pmid:2827647
Bazan HE et al. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. 1987 Biochem. Biophys. Res. Commun. pmid:2827658
Czarnetzki BM [Mediators and the bronchial system. Pathophysiologic and biochemical aspects of mediators of the bronchial system]. 1987 Wien Med Wochenschr Suppl pmid:3078398
Schwertschlag U et al. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. 1987 Circ. Res. pmid:3297384
Tou JS Platelet-activating factor modulates phospholipid acylation in human neutrophils. 1987 Lipids pmid:3110533
Bussolino F et al. Intravascular release of platelet activating factor in children with sepsis. 1987 Thromb. Res. pmid:3441909
Bossant MJ et al. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection. 1987 J. Chromatogr. pmid:3443654
Parker CW Lipid mediators produced through the lipoxygenase pathway. 1987 Annu. Rev. Immunol. pmid:3036183
Vane J and Botting R Inflammation and the mechanism of action of anti-inflammatory drugs. 1987 FASEB J. pmid:3111928
Shimizu K et al. [Actions of platelet activating factor in pulmonary circulation--experimental investigation using rabbit blood vessel smooth muscle preparations]. 1987 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3444152
Riedel A and Mest HJ The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites. 1987 Prostaglandins Leukot Med pmid:3112804
Lagente V et al. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists. 1987 Braz. J. Med. Biol. Res. pmid:3452452
Shimokawa H et al. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. 1987 Circ. Res. pmid:3113760
Gentry PA et al. Inhibitory effect of trichothecene mycotoxins on bovine platelets stimulated by platelet activating factor. 1987 Can. J. Vet. Res. pmid:3453270
Sugatani J et al. Potential involvement of vicinal sulfhydryls in stimulus-induced rabbit platelet activation. 1987 J. Biol. Chem. pmid:2824509
Adnot S et al. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. 1987 Agents Actions pmid:3115070
Montrucchio G et al. The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. 1987 Agents Actions pmid:3115072
Evans TW et al. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. 1987 J. Appl. Physiol. pmid:3115939
Knudsen BS et al. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. 1987 J. Clin. Invest. pmid:3116043
Feuerstein G and Hallenbeck JM Prostaglandins, leukotrienes, and platelet-activating factor in shock. 1987 Annu. Rev. Pharmacol. Toxicol. pmid:3034139
Bussolino F et al. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. 1987 J. Immunol. pmid:3116081
Bitterman H et al. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. 1987 Methods Find Exp Clin Pharmacol pmid:3116357
Gateau O [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. 1987 Arch Mal Coeur Vaiss pmid:3117010
Sperling RI et al. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. 1987 J. Immunol. pmid:2826583
Michel L et al. Biologic properties of LTB4 and paf-acether in vivo in human skin. 1987 J. Invest. Dermatol. pmid:3035030
Touqui L et al. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. 1987 Biochem. J. pmid:3109377
Bureau M et al. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. 1987 Prostaglandins pmid:3035615
Moodley I and Stuttle A Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes. 1987 Prostaglandins pmid:3035617
Satouchi K et al. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes. 1987 Lipids pmid:3110532
Di Marzo V et al. Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung. 1987 Neuropeptides pmid:3031537